Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells

被引:16
作者
Coffman, TM
Spurney, RF
Mannon, RB
Levenson, R
机构
[1] Vet Affairs Med Ctr, Durham, NC 27705 USA
[2] Duke Univ, Dept Med, Durham, NC 27705 USA
[3] Duke Univ, Dept Pathol, Durham, NC 27705 USA
关键词
plasminogen activator inhibitor-1; tissue plasminogen activator; thromboxane receptor; glomerulonephritis;
D O I
10.1152/ajprenal.1998.275.2.F262
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We examined the effects of thromboxane A(2) (TxA(2)) on the activities of the plasminogen-plasmin system in glomerular mesangial cells. When mesangial cells are exposed to the TxA(2) agonist U-46619, a substantial increase in production of plasminogen activator inhibitor-1 (PAI-1) protein is observed that is significantly greater than that induced by 10% serum alone. This increase in PAI-1 protein production is accompanied by an increase in steady-state levels of PAI-1 mRNA. This stimulation is specifically mediated by TxA(2) (thromboxane prostanoid, TP) receptors, since U-46619 also stimulates PAI-1 expression in cells that are transfected with TP receptors, and this stimulation of PAI-1 production is completely blocked by the TxA(2) receptor antagonist, SQ-29,548. Despite the increase in PAI-1 production, there was net stimulation of plasmin activity in the medium of mesangial cells that had been exposed to U-46619. Furthermore, U-46619 also caused an increase in tissue plasminogen activator (tPA) mRNA levels. Thus TxA(2) stimulates the production of PAI-1 and plasminogen activators by mesangial cells through a receptor-dependent mechanism. In inflammatory renal diseases, the balance of these effects may modulate glomerular thrombosis and renal fibrosis.
引用
收藏
页码:F262 / F269
页数:8
相关论文
共 48 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[2]  
BAYLIS C, 1987, RENAL PHYSIOL BIOCH, V10, P110
[3]   THROMBOXANE STIMULATES SYNTHESIS OF EXTRACELLULAR-MATRIX PROTEINS INVITRO [J].
BRUGGEMAN, LA ;
HORIGAN, EA ;
HORIKOSHI, S ;
RAY, PE ;
KLOTMAN, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03) :F488-F494
[4]   MECHANISM OF GLUCOCORTICOID INDUCTION OF THE RAT PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE IN HTC RAT HEPATOMA-CELLS - IDENTIFICATION OF CIS-ACTING REGULATORY ELEMENTS [J].
BRUZDZINSKI, CJ ;
JOHNSON, MR ;
GOBLE, CA ;
WINOGRAD, SS ;
GELEHRTER, TD .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (09) :1169-1177
[5]  
CHEN CA, 1988, BIOTECHNIQUES, V6, P632
[6]  
COLLINS DM, 1991, ACUTE RENAL FAILURE, P13
[7]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[8]   Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene [J].
Eitzman, DT ;
McCoy, RD ;
Zheng, XX ;
Fay, WP ;
Shen, TL ;
Ginsburg, D ;
Simon, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :232-237
[9]   GLUCOCORTICOID REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 MESSENGER-RIBONUCLEIC-ACID AND PROTEIN IN NORMAL AND MALIGNANT RAT OSTEOBLASTS [J].
FUKUMOTO, S ;
ALLAN, EH ;
ZEHEB, R ;
GELEHRTER, TD ;
MARTIN, TJ .
ENDOCRINOLOGY, 1992, 130 (02) :797-804
[10]   CDNA CLONING OF HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR FROM ENDOTHELIAL-CELLS [J].
GINSBURG, D ;
ZEHEB, R ;
YANG, AY ;
RAFFERTY, UM ;
ANDREASEN, PA ;
NIELSEN, L ;
DANO, K ;
LEBO, RV ;
GELEHRTER, TD .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1673-1680